Attached files

file filename
EX-31.1 - EX-31.1 - Blackhawk Biofuels, LLCa09-31619_1ex31d1.htm
EX-32.2 - EX-32.2 - Blackhawk Biofuels, LLCa09-31619_1ex32d2.htm
EX-31.2 - EX-31.2 - Blackhawk Biofuels, LLCa09-31619_1ex31d2.htm
EX-32.1 - EX-32.1 - Blackhawk Biofuels, LLCa09-31619_1ex32d1.htm

Table of Contents

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

x

Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

 

 

For the quarterly period ended September 30, 2009

 

 

o

Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934.

 

 

For the transition period from                    to                  

 

Commission file number 000-53651

 

BLACKHAWK BIOFUELS, LLC

(Exact name of registrant as specified in its charter)

 

Delaware
(State or other jurisdiction of
incorporation or organization)

 

20-2760722
(I.R.S. Employer Identification No.)

 

210 West Spring Street

Freeport, Illinois 61032

(Address of principal executive offices)

 

(815) 235-2461

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or l5(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  x Yes  o No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  o Yes  o No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act).

 

Large accelerated filer o

 

Accelerated filer o

 

 

 

Non-accelerated filer o
(Do not check if a smaller reporting company)

 

Smaller reporting company x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  o Yes  x No

 

 

 



Table of Contents

 

TABLE OF CONTENTS

 

FORWARD LOOKING STATEMENTS

 

3

 

 

 

PART 1. FINANCIAL INFORMATION

 

 

 

 

 

Item 1. Financial Statements

 

5

 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

25

 

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

35

 

 

 

Item 4. Controls and Procedures

 

35

 

 

 

PART 2. OTHER INFORMATION

 

 

 

 

 

Item 1. Legal Proceedings

 

35

 

 

 

Item 1A. Risk Factors

 

35

 

 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

35

 

 

 

Item 3. Defaults Upon Senior Securities

 

37

 

 

 

Item 4. Submission of Matters to a Vote of Security Holders

 

37

 

 

 

Item 5. Other Information

 

37

 

 

 

Item 6. Exhibits

 

37

 

 

 

SIGNATURES

 

 

 

 

 

EXHIBITS

 

 

 

2



Table of Contents

 

FORWARD LOOKING STATEMENTS

 

This report contains forward-looking statements involving future events, future business, industry and other conditions, our future performance, and our plans and expectations for future operations and actions.  In many cases, you can identify forward-looking statements by the use of words such as “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate,” “predict,” “hope,” “should,” “could,” “may,” “future,” “continue,” “potential,” or other forms or the negatives of these terms or other similar expressions.  Many of these forward-looking statements are located in this report under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” but they may appear in other sections as well.

 

These forward-looking statements are based on assumptions that we believe to be reasonable, beliefs and expectations in reliance on information currently available to management and our estimates regarding future results, trends and uncertainties.  We caution you not to put undue reliance on any forward-looking statements.

 

You should read this report thoroughly with the understanding that our actual results may differ materially from those set forth in the forward-looking statements for many reasons, including events beyond our control and assumptions that prove to be inaccurate or unfounded.  We cannot provide any assurance with respect to our future performance or results.  Although we believe that our plans and objectives, as reflected in or suggested by the forward-looking statements, are reasonable, we may never achieve our plans or objectives.  Actual results may differ from anticipated or desired results due to many possible unforeseen developments, including developments arising from or relating to the following:

 

·                  The suitability of our biodiesel plant location, adequacy of required infrastructure and quality of construction of our plant;

 

·                  Competition and technological developments in the biodiesel industry and the energy market generally;

 

·                  Economic, competitive and business conditions in our local and regional markets and in the national and international marketplace;

 

·                  The availability and continuance of environmental and other permits, licenses and incentives;

 

·                  The impact of or changes in laws or regulations relating to the biodiesel or energy industry, environmental matters and taxation;

 

·                  Our ability to generate cash flow to meet our operating needs, repay indebtedness and make distributions to our Unit holders;

 

·                  The performance of our consultants, contractors and suppliers;

 

·                  The actions of national, state and local legislative, regulatory and judicial bodies and authorities;

 

·                  Delays or interruptions in the operation of our plant due to inadequate financing, design or material failures, environmental issues, lack of raw materials, transportation blockages, weather and other factors; and

 

·                  The necessity to modify or upgrade our plant, expand or curtail our operations, obtain additional capital or change our business strategy.

 

·                  Our ability to negotiate satisfactory revisions to or replacements for our term loan and revolving credit loans.

 

3



Table of Contents

 

·                  The successful completion of our pending consolidation with REG and other biodiesel producers.

 

The forward-looking statements contained in this report speak as of the date of this report and are subject to events and developments occurring after the date of this report.  Except as may be required under the federal securities laws, we do not undertake any obligation to update any forward-looking statements in this report to reflect future events or developments.

 

We are not under any duty to update the forward-looking statements contained in this report.  We cannot guarantee future results, levels of activity, performance or achievements.  We caution you not to put undue reliance on any forward-looking statements, which speak only as of the date of this report.  You should read this report and the documents that we reference in this report and have filed as exhibits completely and with the understanding that our actual future results may be materially different from what we currently expect.  We qualify all of our forward-looking statements by these cautionary statements.

 

4



Table of Contents

 

PART I – FINANCIAL INFORMATION

 

Item 1.  Financial Statements.

 

BLACKHAWK BIOFUELS, LLC

 

Condensed Balance Sheets

 

 

 

September 30,

 

December 31,

 

 

 

2009

 

2008

 

 

 

(Unaudited)

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

Current Assets

 

 

 

 

 

Cash

 

$

119,280

 

$

730,234

 

Restricted cash

 

2,003,413

 

6,844,804

 

Accounts receivable - related party

 

332,921

 

 

Other receivable

 

200,000

 

200,000

 

Inventories

 

94,223

 

1,322,856

 

Deposits

 

4,200

 

 

Prepaid expenses

 

124,835

 

168,636

 

Total current assets

 

2,878,872

 

9,266,530

 

 

 

 

 

 

 

Property, Plant and Equipment

 

 

 

 

 

Buildings

 

23,349,790

 

11,553,691

 

Computers and office equipment

 

174,281

 

161,665

 

Plant and process equipment

 

37,366,452

 

36,809,408

 

Site improvements

 

5,457,677

 

5,457,677

 

Construction in process

 

 

10,119,296

 

Total property, plant and equipment

 

66,348,200

 

64,101,737

 

Less accumulated depreciation

 

2,874,044

 

204,920

 

Net property, plant and equipment

 

63,474,156

 

63,896,817

 

 

 

 

 

 

 

Other Assets

 

 

 

 

 

Debt issuance costs, net of amortization

 

276,322

 

368,431

 

Total other assets

 

276,322

 

368,431

 

 

 

 

 

 

 

Total Assets

 

$

66,629,350

 

$

73,531,778

 

 

 

 

 

 

 

LIABILITIES AND EQUITY

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

Current maturities of long-term debt

 

$

24,444,583

 

$

1,848,753

 

Line of credit

 

414,553

 

 

Accounts payable

 

863,127

 

214,221

 

Accounts payable - related party

 

491,589

 

64,088

 

Construction payable - related party

 

199,965

 

2,109,985

 

Commodity derivative instruments, at fair value

 

 

95,712

 

Interest rate swap, at fair value

 

1,159,080

 

1,413,037

 

Accrued expenses

 

360,722

 

58,216

 

Accrued interest

 

423,477

 

567,899

 

Total current liabilities

 

28,357,096

 

6,371,911

 

 

 

 

 

 

 

Long-Term Debt, net of $74,415 and $89,771 unamortized debt discount at September 30, 2009 and December 31, 2008, respectively

 

21,625,585

 

44,411,476

 

 

 

 

 

 

 

Members’ Equity

 

 

 

 

 

Member contributions, net of costs related to capital contributions, 16,915,759 and 16,404,267 units outstanding at September 30, 2009 and December 31, 2008, respectively

 

29,657,543

 

28,634,557

 

Additional paid in capital

 

990,124

 

990,124

 

Deficit accumulated

 

(14,000,998

)

(6,876,290

)

Total members’ equity

 

16,646,669

 

22,748,391

 

 

 

 

 

 

 

Total Liabilities and Members’ Equity

 

$

66,629,350

 

$

73,531,778

 

 

Notes to Financial Statements are an integral part of this Statement.

 

5



Table of Contents

 

BLACKHAWK BIOFUELS, LLC

 

Condensed Statements of Operations

 

 

 

Three Months

 

Three Months

 

Nine Months

 

Nine Months

 

 

 

Ended

 

Ended

 

Ended

 

Ended

 

 

 

September 30, 2009

 

September 30, 2008

 

September 30, 2009

 

September 30, 2008

 

 

 

(Unaudited)

 

(Unaudited)

 

(Unaudited)

 

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

 

 

 

 

 

 

 

 

Sales to related party

 

$

2,638,575

 

$

 

$

6,119,117

 

$

 

Federal incentives

 

 

 

49,733

 

 

Total

 

2,638,575

 

 

6,168,850

 

 

 

 

 

 

 

 

 

 

 

 

Cost of Goods Sold

 

2,604,363

 

 

8,403,297

 

 

 

 

 

 

 

 

 

 

 

 

Gross Profit (Loss)

 

34,212

 

 

(2,234,447

)

 

 

 

 

 

 

 

 

 

 

 

Operating Expenses

 

 

 

 

 

 

 

 

 

Professional fees

 

355,681

 

65,770

 

1,257,615

 

457,216

 

General and administrative

 

604,778

 

312,865

 

1,699,024

 

842,466

 

Total

 

960,459

 

378,635

 

2,956,639

 

1,299,682

 

 

 

 

 

 

 

 

 

 

 

Operating Loss

 

(926,247

)

(378,635

)

(5,191,086

)

(1,299,682

)

 

 

 

 

 

 

 

 

 

 

Other Income (Expense)

 

 

 

 

 

 

 

 

 

Other income

 

18

 

 

 

3,673

 

18,777

 

Loss on commodity derivative instruments

 

 

(264,598

)

 

(264,598

)

Interest income

 

1,630

 

51,165

 

6,555

 

891,625

 

Change in fair value of interest rate swap agreement

 

(16,719

)

21,016

 

253,957

 

(44,972

)

Interest expense

 

(731,598

)

 

(2,197,807

)

(741

)

Total

 

(746,669

)

(192,417

)

(1,933,622

)

600,091

 

 

 

 

 

 

 

 

 

 

 

Net Loss

 

$

(1,672,916

)

$

(571,052

)

$

(7,124,708

)

$

(699,591

)

 

 

 

 

 

 

 

 

 

 

Weighted Average Units Outstanding- Basic

 

16,729,513

 

16,165,230

 

16,729,513

 

12,741,032

 

 

 

 

 

 

 

 

 

 

 

Net Loss Per Unit - Basic

 

$

(0.10

)

$

(0.04

)

$

(0.43

)

$

(0.05

)

 

 

 

 

 

 

 

 

 

 

Weighted Average Units Outstanding- Diluted

 

16,729,513

 

16,165,230

 

16,729,513

 

12,741,032

 

 

 

 

 

 

 

 

 

 

 

Net Loss Per Unit - Diluted

 

$

(0.10

)

$

(0.04

)

$

(0.43

)

$

(0.05

)

 

Notes to Financial Statements are an integral part of this Statement.

 

6



Table of Contents

 

BLACKHAWK BIOFUELS, LLC

 

Condensed Statements of Cash Flows

 

 

 

Nine Months

 

Nine Months

 

 

 

Ended

 

Ended

 

 

 

September 30, 2009

 

September 30, 2008

 

 

 

(Unaudited)

 

(Unaudited)

 

 

 

 

 

 

 

Cash Flows from Operating Activities

 

 

 

 

 

Net loss

 

$

(7,124,708

)

$

(699,591

)

Adjustments to reconcile net loss to net cash from operations:

 

 

 

 

 

Compensation recognized from warrant issuance

 

 

256,308

 

Units issued as payment for interest incurred

 

592,572

 

 

Units issued in exchange for services

 

 

52,500

 

Depreciation and amortization

 

2,776,589

 

56,579

 

Realized loss on commodities derivative instruments

 

 

(1,079

)

Unrealized loss on interest rate swap

 

(253,957

)

(44,972

)

Unrealized gain (loss) on commodities derivative instruments

 

(95,712

)

264,598

 

Change in assets and liabilities:

 

 

 

 

 

Other receivables

 

 

(150,000

)

Accounts receivable - related party

 

(332,921

)

 

Deposits

 

(4,200

)

 

Inventories

 

1,228,633

 

(206,540

)

Prepaid expenses

 

43,801

 

(113,565

)

Accounts payable

 

648,905

 

(107,754

)

Accounts payable - related party

 

427,501

 

 

Accrued expenses

 

588,498

 

520,059

 

Net cash provided by (used for) operating activities

 

(1,504,998

)

173,457

 

 

 

 

 

 

 

Cash Flows from Investing Activities

 

 

 

 

 

Proceeds from (payments for) restricted cash

 

4,841,391

 

(15,841,899

)

Capital expenditures

 

(2,246,463

)

(3,865

)

Construction payable - related party

 

(1,910,020

)

 

Construction in process

 

 

(32,583,675

)

Net cash provided by (used for) investing activities

 

684,908

 

(48,429,439

)

 

 

 

 

 

 

Cash Flows from Financing Activities

 

 

 

 

 

Payments for debt issuance costs

 

 

(446,967

)

Member contributions received

 

 

25,102,000

 

Proceeds from construction loan

 

 

24,648,768

 

Payments for construction loan

 

(205,417

)

 

Proceeds from line of credit

 

880,000

 

 

Payments for line of credit

 

(465,447

)

 

Payments for deferred offering costs

 

 

(86,617

)

Forfeited deposit

 

 

2,500

 

Net cash provided by financing activities

 

209,136

 

49,219,684

 

 

 

 

 

 

 

Net Increase (Decrease) in Cash

 

(610,954

)

616,789

 

 

 

 

 

 

 

Cash — Beginning of Period

 

730,234

 

7,042

 

 

 

 

 

 

 

Cash — End of Period

 

$

119,280

 

$

623,831

 

 

 

 

 

 

 

Supplemental Disclosure of Cash Flow Information

 

 

 

 

 

Cash paid during the period for:

 

 

 

 

 

Capitalized interest

 

$

 

$

390,680

 

Interest paid

 

$

1,211,777

 

$

741

 

 

 

 

 

 

 

Supplemental Disclosure of Noncash Investing and Financing Activities

 

 

 

 

 

Non-operating assets exchanged for debt

 

$

 

$

21,700,000

 

Construction costs included in construction payable

 

$

199,965

 

$

3,289,387

 

Units issued to pay accrued interest

 

$

430,414

 

$

239,875

 

 

7



Table of Contents

 

BLACKHAWK BIOFUELS, LLC

 

Notes to Condensed Financial Statements (Unaudited)

 

September 30, 2009 and December 31, 2008

 

1.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The accompanying unaudited interim condensed financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted as permitted by such rules and regulations. These financial statements and related notes should be read in conjunction with the financial statements and notes thereto included in the Company’s audited financial statements for the year ended December 31, 2008, contained in the Company’s annual report on Form 10-K.

 

In the opinion of management, the interim financial statements reflect all adjustments considered necessary for fair presentation. The adjustments made to these statements consist only of normal recurring adjustments. Operating results for the periods presented are not necessarily indicative of the results that may be expected for the year ended December 31, 2009.

 

Nature of Business

 

The Company, which anticipated its plant location to be in Stephenson County, Illinois, was organized to fund and construct a 30 million gallon biodiesel production facility.  The Company was formed on April 28, 2005 to have an indefinite life.

 

As of March 14, 2008, the Company abandoned the aforementioned project and purchased the under construction assets of an existing project located in Danville, Illinois (the plant) from an unrelated third party. This existing project was organized by the unrelated party to fund and construct a 45 million gallon biodiesel production facility.  The Company completed the construction of the plant and placed the assets into service in December 2008. The Company was in development stage until January 2009, when the Company commenced operations.  The Company’s animal fat production facility became operational in March 2009.

 

Accounting Estimates

 

Management uses estimates and assumptions in preparing these financial statements in accordance with generally accepted accounting principles in the United States of America.  Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. The Company uses estimates and assumptions in accounting for the following significant matters; useful life of property, plant and equipment; valuation of derivatives, inventories and property, plant and equipment, share-based compensation, the allocation of construction in process and other contingencies. Actual results may differ from previously estimated amounts, and such differences may be material to the financial statements. The Company periodically reviews estimates and assumptions, and the effects of any such revisions are reflected in the period in which the revision is made.

 

8



Table of Contents

 

BLACKHAWK BIOFUELS, LLC

 

Notes to Condensed Financial Statements (Unaudited)

 

September 30, 2009 and December 31, 2008

 

Revenue Recognition

 

Revenues are recognized when the customer has taken title and has assumed the risks and rewards of ownership, prices are fixed or determinable, and collectability is reasonably assured.

 

The Company is a registered blender of gasoline, diesel fuel, or kerosene outside the bulk transfer/terminal system pursuant to Internal Revenue Code Section 4101.  The Company blends a portion of its finished biodiesel with .01% diesel fuel prior to sale to its customers, to produce B99.9 biodiesel.  Those sales are eligible for a $1.00 federal tax refund (Federal Blenders Credit).  Since commencement of operations in January 2009, the Company has recognized approximately $49,740 of federal incentive income.  During the three months ended September 30, 2009, due to the terms of the tolling agreement with REG, the Company is no longer is entitled to and is not collecting these federal credits (see Note 7).

 

Restricted Cash

 

Restricted cash consists of project funds and debt reserve funds related to the Company’s construction loan and totaled $2,003,413 and $6,844,804 at September 30, 2009 and December 31, 2008, respectively.  The project funds to facilitate the construction of the plant and the animal fat processing facility have been restricted for purposes in accordance with the terms of a loan agreement with a third party lender (See Note 6).  As of September 30, 2009 and December 31, 2008 there are no other bank or legal restrictions on this cash.

 

Accounts Receivable

 

Accounts receivable are recorded at their estimated net realizable value.  Accounts are considered past due if payment is not made on a timely basis in accordance with the Company’s credit terms.  Accounts considered uncollectible are written off.  The Company’s estimate of the allowance for doubtful accounts is based on historical experience, its evaluation of the current status of receivables, and unusual circumstances, if any.  At September 30, 2009 and December 31, 2008, the Company was of the belief that such amounts would be collectible and thus an allowance was not considered necessary.  It is at least reasonably possible this estimate will change in the future.

 

One related party customer comprised 100% of trade accounts receivable at September 30, 2009.  Among other services, the related party provides management services for the Company.

 

This related party is also engaged to sell substantially all of the Company’s biodiesel, and its by-products, namely glycerin and fatty acid.  The marketer handles nearly all sales functions including billing, logistics, and sales pricing.  Once biodiesel and glycerin is shipped, the marketer assumes the risk of payment from the consumer and handles all delinquent payment issues.

 

9



Table of Contents

 

BLACKHAWK BIOFUELS, LLC

 

Notes to Condensed Financial Statements (Unaudited)

 

September 30, 2009 and December 31, 2008

 

Long-Lived Assets

 

Long-lived assets, such as property, plant and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by an asset to the carrying value of the asset. If the carrying value of the long-lived asset is not recoverable on an undiscounted cash flow basis, impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals, as considered necessary.

 

In 2008, the Company completed construction of its biodiesel production facilities, with installed capacity of 45 million gallons per year. The carrying value of these facilities at September 30, 2009 is approximately $63.5 million. In accordance with the Company’s policy for evaluating impairment of long-lived assets described above, management has evaluated the recoverability of the facilities based on projected future cash flows from operations over the facilities’ estimated useful lives.  Management has determined that the projected future undiscounted cash flows from operations of these facilities exceed their carrying value at September 30, 2009; therefore, no impairment loss was indicated or recognized.  In determining the projected future undiscounted cash flows, the Company has made significant assumptions concerning the future viability of the biodiesel industry, the future price of feedstocks in relation to the future price of biodiesel and the overall demand in relation to production and supply capacity.  Given the recent completion of the facilities, replacement cost would likely approximate the carrying value of the facilities.  However, there have been recent transactions between independent parties to purchase plants at prices substantially below the carrying value of the facilities.  Some of the facilities have been in bankruptcy and may not be representative of transactions outside of bankruptcy.  Given these circumstances, should management be required to adjust the carrying value of the facilities to fair value at some future point in time, the adjustment could be significant and could significantly impact the Company’s financial position and results of operations.  No adjustment has been made in these financial statements for this uncertainty.

 

Subsequent Events

 

The Company has evaluated subsequent events through November 13, 2009, the date which the financial statements were available to be issued.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s cash and restricted cash, accounts receivable, accounts payable, and derivative instruments approximate their carrying value.   The Company believes the carrying amount of the line of credit and construction loan payable approximates the fair value due to the variable interest rate.

 

10



Table of Contents

 

BLACKHAWK BIOFUELS, LLC

 

Notes to Condensed Financial Statements (Unaudited)

 

September 30, 2009 and December 31, 2008

 

Net Loss per Unit

 

Net loss per unit is calculated on a basic and fully diluted basis using the weighted average units outstanding during the period.  Warrants and unit options, representing 801,563 equivalent units, are not considered in the fully diluted calculation since they are anti-dilutive.

 

Recently Adopted Accounting Pronouncements

 

In June 2009, the FASB issued Topic 105 — Generally Accepted Accounting Principles Amendments Based on Statement of Financial Accounting Standards No. 168 — The FASB Accounting Standards Codification and the Hierarchy of Generally Accepted Accounting Principles (Accounting Standards Update (ASU) No. 2009-01), which updates the FASB Accounting Standards Codification (ASC or Codification) to state that the Codification is to be the single source of authoritative GAAP, other than the guidance put forth by the SEC.  All other accounting literature not included in the Codification is to be considered non-authoritative.  The updates to the Codification contained in ASU No. 2009-01 were effective for interim and annual periods ending after September 15, 2009.  The Company implemented the guidance set forth by ASU No. 2009-01, recognizing the Codification as the single source of authoritative GAAP, other than the guidance put forth by the SEC, on July 1, 2009. The implementation did not have a material impact on the Company’s financial statements.

 

2.  MEMBERS’ EQUITY

 

The Company was capitalized by 108 members contributing a total of $3,500,000 for 3,500,000 Class A Units.  These contributions were pursuant to a private placement memorandum in which the Company offered a maximum of 3,500,000 units at a cost of $1.00 per unit for a maximum of $3,500,000.  Each investor was required to purchase a minimum of 25,000 units for a minimum investment of $25,000 and had the option to purchase additional units in increments of 2,500 units thereafter.  This offering was closed and the units were issued on April 12, 2006.  The total amount raised in the offering and released from escrow as March 14, 2008, the date the Company broke escrow, totaled $25,102,000 for the issuance of 12,551,000 units.  These funds were used to provide financing to complete the Company’s biodiesel facility in Danville, Illinois.

 

As specified in the Company’s limited liability company agreement, the Company is authorized to issue additional units as needed.  The Company has one class of units, which include certain transfer restrictions as specified in the limited liability company agreement and pursuant to applicable tax and securities laws.  Each unit represents a pro rata ownership interest in the Company’s profits, losses and distributions.

 

Pursuant to the terms of the subordinated debt agreement with Renewable Energy Group (REG), as of September 30, 2009, the Company has issued a total of 838,509 units to REG as payment of the interest accrued on the subordinated debt (See Note 6) since commencement of the note, which totaled $1,677,023.  During the nine months ended September 30, 2009, the company issued 511,493 units for the payment of accrued interest and interest expense to REG of $1,022,980.  Subsequent to September 30, 2009 the company issued 146,560 units to REG in the amount of $293,121.

 

11



Table of Contents

 

BLACKHAWK BIOFUELS, LLC

 

Notes to Condensed Financial Statements (Unaudited)

 

September 30, 2009 and December 31, 2008

 

3. INVENTORIES

 

Inventories consist of the following:

 

 

 

September 30, 2009

 

December 31, 2008

 

Raw materials

 

$

94,223

 

$

1,248,549

 

Finished goods

 

 

74,307

 

Total

 

$

94,223

 

$

1,322,856

 

 

4. DERIVATIVE INSTRUMENTS

 

From time to time the Company enters into derivative transactions to hedge its exposures to interest rate and commodity price fluctuations. The Company does not enter into derivative transactions for trading purposes.

 

FASB ASC 815-10-50 requires holders of derivative instruments to provide qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of gains and losses from derivative instruments, and disclosures about credit-risk-related contingent features in derivative agreements.

 

The Company adopted this statement effective with the first quarter of 2009.

 

As of September 30, 2009, the Company has entered into an interest rate swap agreement. FASB ASC 815-10-05 requires that companies record derivative financial instruments as either assets or liabilities at fair value in the statement of financial position.  In the past, the Company has also used commodity derivative instruments but did not have any in place at September 30, 2009.

 

Derivatives qualify for treatment as hedges when there is a high correlation between the change in fair value of the derivative instrument and the related change in value of the underlying hedged item. Furthermore, the Company must designate the hedging instruments based upon the exposure being hedged as a fair value hedge, a cash flow hedge or a hedge against foreign currency exposure.  The Company formally documents, designates, and assesses the effectiveness of transactions that receive hedge accounting initially and on an on-going basis.  There were no hedge contracts that qualified for this treatment as of September 30, 2009 or December 31, 2008.

 

Commodity Contracts

 

The Company may engage in heating oil and soy oil commodity-based derivatives in order to protect cash flows from fluctuations caused by volatility in commodity prices for periods up to twelve months in order to protect gross profit margins from potentially adverse effects of market and price volatility on biodiesel sales and soy oil purchase commitments where the prices are set at a future date.  In addition, the Company may hedge anticipated sales of biodiesel to minimize its exposure to the potentially adverse effect of price volatility.  These derivatives are not designated as effective hedges for accounting purposes. For derivative instruments that are not accounted for as hedges, or for the ineffective portions of qualifying hedges, the change in fair value was recorded through earnings in the period of change.

 

12



Table of Contents

 

BLACKHAWK BIOFUELS, LLC

 

Notes to Condensed Financial Statements (Unaudited)

 

September 30, 2009 and December 31, 2008

 

Derivative instruments changes in fair market value were included in cost of goods sold.  As of September 30, 2009, the Company did not have any outstanding soy oil or heating oil futures or options contracts nor did the Company engage in any commodities hedging activity during the quarter ended September 30, 2009.

 

Interest Rate Contracts

 

The Company manages its floating rate debt using interest rate swaps. The Company will enter into fixed rate swaps to alter its exposure to the impact of changing interest rates on its results of operations and future cash outflows for interest. Fixed rate swaps are used to reduce the Company’s risk of the possibility of increased interest costs. Interest rate swap contracts are therefore used by the Company to separate interest rate risk management from the debt funding decision.

 

At September 30, 2009, the Company had outstanding approximately a $24.44 million notional amount swap agreement that exchanges a variable interest rate (LIBOR) for fixed rate of interest over the term of the agreement that is not designated as an effective hedge for accounting purposes and the fair market value gains or losses are included in the results of operations and are classified in change in fair value of interest rate swap agreement.  This swap matures November 3, 2011.

 

The following tables provide details regarding the Company’s derivative financial instruments at September 30, 2009:

 

 

 

Asset Derivatives

 

Liability Derivatives

 

 

 

2009

 

2009

 

As of September 30

 

Balance Sheet
 Location

 

Fair
 Value

 

Balance Sheet
 Location

 

Fair
 Value

 

 

 

 

 

 

 

 

 

 

 

Derivative not designated as hedging instrument under FASB ASC 815-10-05

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swap

 

 

 

 

Interest rate swap

 

$

1,159,080

 

 

 

 

 

 

 

 

 

 

 

Total derivative not designated as hedging instrument FASB ASC 815-10-05

 

 

 

$

 

 

 

$

1,159,080

 

 

 

 

 

 

 

 

 

 

 

Total Derivative

 

 

 

$

 

 

 

$

1,159,080

 

 

13



Table of Contents

 

BLACKHAWK BIOFUELS, LLC

 

Notes to Condensed Financial Statements (Unaudited)

 

September 30, 2009 and December 31, 2008

 

Derivatives not Designated as
Hedging Instruments under FASB
ASC 815-10-05

 

Location of Loss
Recognized in
Income

 

Amount of
Loss
Recognized
in Income
on
Derivatives -
Three
Months
ended
September
30, 2009

 

Amount of
Gain (Loss)
Recognized in
Income on
Derivatives -
Three Months
ended
September
30, 2008

 

Amount of
Gain
Recognized in
Income on
Derivatives -
Nine Months
ended
September
30, 2009

 

Amount of
Loss
Recognized
in Income on
Derivatives -
Nine Months
ended
September
30, 2008

 

 

 

 

 

 

 

 

 

 

 

 

 

Commodities derivative instruments

 

Cost of goods sold

 

$

 

$

 

$

48,272

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

Commodities derivative instruments

 

Other income/(expense)

 

 

 

(264,598

)

 

 

(264,598

)

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swap

 

Change in fair value of interest rate swap agreement

 

(16,719

)

21,016

 

253,957

 

(44,972

)

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

$

(16,719

)

$

(243,582

)

$

302,229

 

$

(309,570

)

 

5. FAIR VALUE MEASUREMENTS

 

Effective January 1, 2008, the Company adopted FASB ASC 820-10-05, as it applies to our financial instruments, and FASB ASC 825-10-10.  FASB ASC 820-10-05 defines fair value, outlines a framework for measuring fair value, and details the required disclosures about fair value measurements. FASB ASC 825-10-10 permits companies to irrevocably choose to measure certain financial instruments and other items at fair value.

 

FASB ASC 825-10-10 also establishes presentation and disclosure requirements designed to facilitate comparison between entities that choose different measurement attributes for similar types of assets and liabilities.  Except for those assets and liabilities which are required to be recorded at fair value the Company elected not to record any other assets or liabilities at fair value, as permitted by FASB ASC 825-10-10.

 

14



Table of Contents

 

BLACKHAWK BIOFUELS, LLC

 

Notes to Condensed Financial Statements (Unaudited)

 

September 30, 2009 and December 31, 2008

 

FASB ASC 820-10-05 defines fair value, outlines a framework for measuring fair value, and details the required disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the principal or most advantageous market. The Company uses a fair value hierarchy that has three levels of inputs, both observable and unobservable, with use of the lowest possible level of input to determine fair value.

 

Level 1 inputs include quoted market prices in an active market or the price of an identical asset or liability. Level 2 inputs are market data, other than Level 1, that are observable either directly or indirectly. Level 2 inputs include quoted market prices for similar assets or liabilities, quoted market prices in an inactive market, and other observable information that can be corroborated by market data. Level 3 inputs are unobservable and corroborated by little or no market data. The Company uses valuation techniques in a consistent manner from year-to-year.

 

The following table provides information on those liabilities measured at fair value on a recurring basis.

 

 

 

Carrying Amount as

 

Fair Value as of

 

Fair Value Measurement Using

 

 

 

of September 30, 2009

 

September 30, 2009

 

Level 1

 

Level 2

 

Level 3

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swap

 

$

(1,159,080

)

$

(1,159,080

)

$

 

$

(1,159,080

)

$

 

 

The Company determines the fair value of the interest rate swap agreement shown in the table above by using widely accepted valuation techniques including discounted cash flow analysis on the expected cash flows of each instrument. The analysis reflects the contractual terms of the derivative instrument, including the period to maturity and uses observable market-based inputs and uses the market standard methodology of netting the discounted future fixed cash receipts and the discounted expected variable cash payments. The variable cash payments are based on an expectation of future interest rates derived from observable market interest rate curves.

 

6.  FINANCING

 

On May 9, 2008 the Company entered into a loan agreement with a third party lender for the purpose of purchasing the assets of the project from the existing owners of the Danville, Illinois project and funding construction and operational requirements for that project.  The agreement provides for a $24,650,000 term loan and a $5,000,000 revolving line of credit.

 

15



Table of Contents

 

BLACKHAWK BIOFUELS, LLC

 

Notes to Condensed Financial Statements (Unaudited)

 

September 30, 2009 and December 31, 2008

 

Interest accrued on the outstanding balance of the term loan at the 30-day LIBOR rate plus 275 basis points until June 30, 2009, at which time the rate was based on the LIBOR rate plus basis points as determined by the Company’s EBITDA.  As of September 30, 2009, the Company’s interest rate totaled 3.07% which included 275 basis points.

 

Interest accrued on the outstanding balance of the loan at September 30, 2009 and December 31, 2008 at 3.07% and 4.65%, respectively.  The term loan will mature on November 3, 2011; however, as described further below, the loan is currently classified as current.  Fixed principal payments totaling $205,417 plus applicable interest commenced during April 2009.  The Company paid the April payment timely as scheduled.  During the quarter ended June 30, 2009, the Company received a proposed amendment from its bank which defers principal payments and allows for interest only payments through December 2009.  The bank has continued to allow the Company to operate under these terms during the quarter ended September 30, 2009 based on a verbal understanding.  The Board approved the proposed amendment during July 2009; however, no definitive amendment has yet been signed by any party as of November 13, 2009.  All remaining principal and accrued but unpaid interest shall be due and payable on the maturity date.

 

The Company is subject to certain financial covenants beginning with the fiscal quarter ending June 30, 2009.  As of September 30, 2009 and November 13, 2009, the Company was not in compliance with the June 30, 2009 and September 30, 2009 covenants as stated in the bank loan agreement.  As of November 13, 2009, the Company has not made principal payments on the loan pursuant to a verbal understanding with its bank of which is based on a proposed amendment as received from its bank.  Because the Company has not yet signed a definitive agreement with the bank, the term loan balance has been classified as a current maturity of long-term debt as of September 30, 2009.  However, based on the proposed amendment with its bank, the minimum fixed charge coverage ratio will not commence until the fiscal quarter ending June 30, 2010 and the maximum funded debt to EFITDA ratio will not commence until the fiscal quarter ending December 31, 2010.  The Company estimates that the bank fee related to the loan amendment will total approximately $61,000.  The bank is engaged in working with the Company to reach amended terms on the loan agreement and has not declared the Company in default under the loan agreement at November 13, 2009.

 

The revolving line of credit will accrue interest at the Company’s choice of the 30-day LIBOR rate plus 300 basis points or the Lender’s prime rate plus 25 basis points and is due in monthly payments.  The Company had a balance of $414,553 at September 30, 2009.  The Company had no outstanding balance on the line of credit as of December 31, 2008.  At September 30, 2009, the Company accrued interest at the 30-day LIBOR plus 300 basis points on the outstanding balance which totaled 3.32%.  The revolving note matured May 8, 2009 and has not yet been renewed.  The Company is currently in negotiations with the third party lender to extend the revolving line of credit to December 31, 2009.

 

16



Table of Contents

 

BLACKHAWK BIOFUELS, LLC

 

Notes to Condensed Financial Statements (Unaudited)

 

September 30, 2009 and December 31, 2008

 

In addition, the third party lender has proposed an interest rate change to the 30-day LIBOR plus 400 basis points.  The proposed terms have been approved final by the Company however no definitive agreement has been signed with the bank.

 

The notes are secured by a mortgage and are subject to financial and other reporting covenants.   The Company must meet certain debt covenants per the terms of the agreement with the bank; these covenants are being negotiated under the proposed term sheet with the bank as noted above.

 

The Company entered into an interest rate swap agreement in relation with the aforementioned bank loan agreement in May 2008.  The swap agreement effectively fixes the Company’s interest rate at 3.67% on a notional amount of $24,445,000 of the Company’s loan through November 2011.  The fair market value of the interest rate swap agreement was a liability of approximately $1,159,000 and $1,413,000 and is recorded as a current liability as of September 30, 2009 and December 31, 2008, respectively.  The interest rate swap agreement is not designated as a cash flow or fair value hedge.

 

Gains and losses based on the fair value change in the interest rate swap agreement are recognized in the statement of operations as change in fair value of interest rate swap agreement.

 

On May 9, 2008, in conjunction with the acquisition of the assets related to the biodiesel project in Danville, Illinois, the Company entered into a Subordinated Loan Agreement with REG in the amount of $21,700,000 (subordinated loan) for the purpose of funding construction of the Danville, Illinois project.

 

The subordinated loan was principally in payment for 1,980,488 shares of common stock of REG and for 127,273 shares of preferred stock of REG issued to an unrelated third party in connection with an oil feedstock supply agreement entered into between the Company and the unrelated third party (See Note 7). The outstanding principal and accrued interest related to the note will be due in full on May 9, 2013.

 

On May 2, 2008, the Company issued a warrant to purchase 51,563 Class A Units at $.01 per unit to REG as part of the subordinated loan agreement.  The warrant was issued to REG in consideration of providing a guaranty for a portion of the Company’s obligations under its Loan agreement with the unrelated third party lender as aforementioned.

 

A debt discount of approximately $102,600, which approximated the relative fair value of the warrants, was recognized at the date of issuance and was amortized and capitalized to construction in process during the construction phase.  As completion of the plant was established in December 2008, the discount is being amortized to interest expense over the remaining life of the loan.  As of September 30, 2009, a total of $12,829 of amortization was capitalized to property during the year ended December 31, 2008.  Total amortization expense for the three and nine months periods ending September 30, 2009 totaled $5,175 and $15,356, respectively.

 

17



Table of Contents

 

BLACKHAWK BIOFUELS, LLC

 

Notes to Condensed Financial Statements (Unaudited)

 

September 30, 2009 and December 31, 2008

 

The note requires the Company to pay interest at the 30 day LIBOR rate plus 500 basis points quarterly beginning July 1, 2008.  The applicable interest rate at September 30, 2009 and December 31, 2008 totaled 5.26% and 6.91%, respectively.  All amounts outstanding under the note, including both principal and interest, shall be convertible at the option of the lender, into units at a price of $2.00 per unit at any time.  The note permits the Company to pay interest in cash or in the form of units valued at $2.00 per unit.  As of September 30, 2009 and December 31, 2008, the Company has issued 838,509 and 327,017, respectively, units to REG (See Note 2). The note is secured by a subordinated mortgage.

 

Long-term debt, as discussed above and excluding the net debt discount of $74,415, consists of the following at September 30, 2009:

 

Construction note

 

$

24,444,583

 

Subordinated debt

 

21,700,000

 

Totals

 

46,144,583

 

Less amounts due within one year

 

24,444,583

 

 

 

 

 

Net long-term debt

 

$

21,700,000

 

 

The estimated maturities of long-term debt at September 30, 2009 are as follows:

 

2009

 

$

24,444,583

 

2010

 

-0-

 

2011

 

-0-

 

2012

 

-0-

 

2013

 

21,700,000

 

 

 

 

 

Total long-term debt

 

$

46,144,583

 

 

The long-term debt is net of the debt discount for outstanding warrants available to REG totaling $74,415 as of September 30, 2009.  Debt discount amortization recognized for the three and nine months ended September 30, 2009 totaled $5,175 and $15,356 respectively, which is recorded in interest expense.

 

7.  COMMITMENTS AND CONTINGENCIES

 

Plant Construction

 

On May 12, 2008 the Company entered into an asset purchase agreement with an unrelated third party for the under-construction assets of the plant located in Danville, IL.  The Company provided the sellers cash totaling $5,250,000 and 1,882,927 common shares of REG.

 

18



Table of Contents

 

BLACKHAWK BIOFUELS, LLC

 

Notes to Condensed Financial Statements (Unaudited)

 

September 30, 2009 and December 31, 2008

 

Of that consideration, $250,000 and 97,561 shares of common stock in REG were placed in escrow to satisfy indemnification obligations which the seller may have to the Company under the Purchase Agreement.  This escrow expired and the cash and stock was released on May 12, 2009.  The Company has assumed $24,650,000 of the sellers’ long-term debt by entering into a new loan agreement with the financial institution (See Note 6).

 

On May 9, 2008, the Company entered into a design-build agreement with REG for the construction of a treatment facility to process animal fats for use as feedstock in the production process. This facility was built within the Danville, IL location. Construction on the animal fat processing plant is complete and the final cost of the plant totaled $11,553,691.  The contract also includes a contingency amount totaling $903,306, which is not included in the aforementioned contract price. Within several days of the Company entering into the purchase agreement as aforementioned, the Company paid 10% of the estimated contract price or $1,085,000, which was applied to the total contract price. A final payment, consisting of the unpaid balance of the contract price, has been billed to the Company, a portion of which is included in construction payable at September 30, 2009 and December 31, 2008.

 

Oil Feedstock Supply Agreement

 

On May 9, 2008, the Company entered into an oil feedstock supply agreement with an unrelated third party.  Under the agreement, the Company will purchase up to approximately 30% of the Company’s maximum operating requirements for soybean oil for a term of six years from the date of closing of the asset purchase agreement. The Company has the option to renew the agreement for an additional two-year period by giving written notice no later than 12 months prior to expiration of the initial term. The Company is obligated to pay the third party the futures price plus basis.

 

A transaction fee totaling the greater of total pounds delivered to the facility during the year multiplied by a flat rate or, if less than 112 million pounds are delivered due to certain circumstances as defined by the agreement, a determined fee as stipulated in the agreement would be owed to the third party provider. The accumulated fee for the three and nine months ended September 30, 2009 totaled $47,300 and $171,070 respectively. Delivery payments are due each week for the total price of oil to be delivered under the applicable weekly estimate.

 

For any oil not covered by specific orders or by a weekly estimate, the Company shall pay in advance the total price for such oil. Beginning October 1, 2008 and continuing for a six month period thereafter, the Company accepted delivery of and paid the unrelated third party for a minimum of 5.75 million pounds of oil. For all subsequent months during the term of the agreement, the Company must accept delivery of and pay for a minimum of 7 million pounds of oil.

 

19



Table of Contents

 

BLACKHAWK BIOFUELS, LLC

 

Notes to Condensed Financial Statements (Unaudited)

 

September 30, 2009 and December 31, 2008

 

Lease Agreements

 

On May 9, 2008, the Company entered into a lease agreement with the same unrelated party providing the oil feedstock supply as aforementioned, for certain real property. The base rent is the sum of one dollar ($1.00) per annum, payable on the rent commencement date and on each anniversary during each year.

 

Upon termination of the oil feedstock supply agreement a base rent of $72,000 per annum is payable in equal monthly installments in advance on the first day of each month throughout the lease term. After the first full calendar year the base rent shall increase by the same percentage as the percentage increase, if any, in the consumer price index.

 

Service Agreements

 

On May 9, 2008, the Company entered into an agreement with an unrelated party to provide assistance with rail loadout services and provide the Company easements for access and natural gas, oil, and biodiesel pipelines. The Company will pay monthly estimated per car cost for all railcars loaded during a month. At the end of each quarter the Company will be notified the actual per car cost for that quarter. If actual is greater than estimated, the Company will be required to pay the difference times the number of railcars loaded during such quarter, payment must be made within five days. The Company shall also pay the pre-effective service fee of $240,000 in monthly payments of $13,333 beginning November 2008.

 

Consulting Contracts

 

In May 2006, the Company entered into an agreement with an unrelated party for consultation and contract negotiations.  The contract required payments totaling $35,000.  In February 2007, the Company extended this agreement.  The contract required payments totaling $25,000, and an additional $25,000 in the form of units of the Company at the time construction begins, which the Company paid upon the purchase of the under-construction assets of the Danville plant.  The consultant was paid in the form of Company units for all scheduled payments discussed under the contract above.

 

Approximately $50,000 of compensation expense relating to the unit issuance was recognized in general and administrative expense on the statement of operations for the year ended December 31, 2008.

 

On May 9, 2008, the Company issued a warrant for the purchase of an additional 100,000 units to this outside consultant for services related to the project.  The warrant is exercisable at a purchase price of $2.00 per unit at any time from and after the date on which the plant commences operations and will continue for a period of seven years following such date, after which all such rights shall terminate. The related warrant-based compensation expense of $142,972 had been recognized as of December 31, 2008, when the plant commenced operations.

 

20



Table of Contents

 

BLACKHAWK BIOFUELS, LLC

 

Notes to Condensed Financial Statements (Unaudited)

 

September 30, 2009 and December 31, 2008

 

On May 9, 2008, pursuant to the acquisition of the assets of the Danville, Illinois project, the Company entered into a management and operational services agreement with REG.  The agreement provides for the overall management of the plant, including providing on-site general and operations managers, procurement of feedstocks as necessary for the operation of the plant, performing administrative, sales, and marketing functions, and other as needed services.

 

The agreement also provides for the extension of trade credit by REG to the Company in connection with the purchase of raw materials and sale of biodiesel by the Company or on the Company’s behalf. The contract requires a monthly fee equal to $.0425 per gallon of biodiesel produced and a flat fee of $75,000 per month however pursuant to entering into a tolling agreement with the Company REG revised this payment.  See the discussion below.  The Company will also pay REG approximately $483,000 for testing and start-up services provided during the development stage. The term of the agreement is five years after the end of the first month in which biodiesel is produced for sale. As of September 30, 2009, the Company has recognized approximately $478,400 related to this agreement.

 

Occurring each month since March 20, 2009, the Company has entered into toll process agreements with REG for the purpose of providing certain feedstock and other raw materials for production of biodiesel.  Under the agreements REG and an unrelated third party would provide for delivery of the feedstock and, depending on the point in the process, either one of those parties would retain title to the goods at all times throughout the production process.

 

The Company will receive a set fee per gallon up to 2,500,000 produced and a reduced fee per gallon thereafter.  The agreement also waived the $.0425 per gallon sold payment payable to REG under the terms of the management and services agreement as noted above.  Payment under the terms of the agreements is dependent on the certification and testing of the finished product biodiesel.  The agreements expire after one month at month end.  Each agreement has had substantially similar terms.

 

8.  TRANSACTIONS WITH RELATED PARTIES

 

The Company entered into a design build and management and operational services agreement (see Note 7) in May 2008 with REG for the operation of the biodiesel plant, and additionally to perform the sales and marketing functions for the plant.  REG is a member of the Company as of September 30, 2009 and December 31, 2008.

 

21



Table of Contents

 

BLACKHAWK BIOFUELS, LLC

 

Notes to Condensed Financial Statements (Unaudited)

 

September 30, 2009 and December 31, 2008

 

Transactions and balances with REG are as follows as of:

 

 

 

September
30, 2009

 

December 31,
2008

 

Balance Sheet:

 

 

 

 

 

Accounts receivable

 

$

332,921

 

$

 

Purchases related to construction of the plant

 

9,094,988

 

9,094,988

 

Accounts payable

 

491,589

 

64,088

 

Construction payable

 

199,965

 

2,109,985

 

Subordinated note payable, gross

 

21,700,000

 

21,700,000

 

Accrued subordinated note interest payable

 

293,121

 

430,414

 

 

 

 

Three Months
ended
September
30, 2009

 

Three
Months
ended
September
30, 2008

 

Nine
Months
ended
September
30, 2009

 

Nine
Months
ended
September
30, 2008

 

Statement of Operations:

 

 

 

 

 

 

 

 

 

Purchases of finished product biodiesel

 

$

 

$

58,216

 

$

 

$

58,216

 

Sales to related party

 

 

 

1,850,709

 

 

Tolling revenue

 

2,638,575

 

 

4,268,408

 

 

Management fees incurred

 

225,000

 

 

703,371

 

 

 

9. GOING CONCERN AND BIODIESEL UNCERTAINTIES

 

The biodiesel market has experienced significant declines during the recent year. The decreases have occurred in conjunction with the decline in most other major commodities and world financial markets in response to the current global economic crisis. This decrease has had a significant impact on the Company’s ability to meet working capital needs and run the plant at full capacity.

 

22



Table of Contents

 

BLACKHAWK BIOFUELS, LLC

 

Notes to Condensed Financial Statements (Unaudited)

 

September 30, 2009 and December 31, 2008

 

As of September 30, 2009, the Company had available capital (cash plus borrowing capacity) of approximately $119,000.  This consisted of approximately $119,000 of cash on hand. The Company had no borrowing capacity available on that date. An additional $2,000,000 in cash is currently held in a restricted debt service fund with the bank which provides the bank the right to draw down any missed or failed payment.

 

The Company has a $5,000,000 revolving line of credit (See Note 6) with approximately $4,585,000 available, however the terms of the agreement require the Company to recognize a minimum gross margin, to be determined by the lender, realized on each gallon of biodiesel before funding could occur.  In addition, the Company must meet the requirements of the borrowing base limitation which is 50% of qualifying inventories and 75% of qualifying receivables.

 

Since December 31, 2008, due to market conditions, the plant has operated below its nameplate capacity. As a consequence, revenue during the first nine months of fiscal year 2009 is less than originally projected. This has caused the Company to utilize more cash than anticipated.

 

Because of these events, as well as the market conditions discussed above, there is an increased level of uncertainty related to its ability to obtain funds from cash flows from operations in fiscal year 2009, or obtain bank financing that is sufficient for the liquidity needed for ongoing operations.

 

These factors raise significant doubt about the Company’s ability to continue as a going concern. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. This basis of accounting contemplates the recovery of the Company’s assets and liabilities in the normal course of business.

 

Management has implemented the following plan:

 

·                  Management has selectively entered into purchase commitments where the price inputs are favorable.

·                  Management continues to enter into monthly tolling agreements with REG to provide a margin to the Company for processing feedstock owned and provided by third parties into biodiesel needed by those customers.

·                  Management is currently in negotiations with its lender to amend and extend existing agreements to assist with potential future working capital needs.

·                  Management, with the completion of the animal fat process, has the ability to increase production in the area of the currently lower input costs, soy oil or animal fat.

·                  The Company has negotiated and agreed to a merger agreement with REG which provides for the consolidation of the Company with REG and two other biodiesel producers.  This execution is pending SEC review and member approval.

 

23



Table of Contents

 

BLACKHAWK BIOFUELS, LLC

 

Notes to Condensed Financial Statements (Unaudited)

 

September 30, 2009 and December 31, 2008

 

10. MERGER AGREEMENT

 

On May 11, 2009, the Company entered into a definitive agreement and plan of merger with REG, for the consolidation of the Company’s commercial-scale biodiesel production facility with REG and two other biodiesel producers.  A new holding company, which has been incorporated by REG, would own and operate the Company and other acquired companies.  The holding company will be owned by current REG investors and the current members of the Company as well as the members of the two other consolidating companies.

 

Per the terms of the agreement, the Company’s existing units will be converted to shares of the new company (Newco) and the Company’s unitholders will receive .4479 of a share of Newco common stock and .0088 of a share of Newco preferred stock for each Class A unit of the Company.   In addition, all outstanding company warrants are will be assumed by Newco and converted into warrants for the purchase of common stock of Newco based on the same exchange ratio as is applicable to outstanding Class A units of the Company as mentioned above.  The exercise date of these warrants will be extended by the number of days in the period between December 19, 2009 and the first anniversary date of the closing date of the merger transaction with REG and Newco.  The transaction is not final and is subject to approvals by the members or shareholders of the consolidating companies as well as the Company’s ability to secure additional working capital financing to fund operations of the plant and its ability to obtain an amended agreement on existing debt with its senior third party lender, amongst other conditions as stated in the agreement.

 

The holding company initially filed a registration statement on Form S-4 with the Securities and Exchange Commission on August 10, 2009.  In response to comments received by the SEC, the holding company filed Amendment No’s 1, 2 and 3 to Form S-4 on October 5, 2009, October 26, 2009 and November 12, 2009, respectively.   The document is currently in review with the SEC.

 

24



Table of Contents

 

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Overview

 

This report contains forward-looking statements that involve significant risks and uncertainties.  The following discussion, which focuses on our plan of operation through the commencement of operations of our plant, consists almost entirely of forward-looking information and statements.  Actual events or results may differ materially from those indicated or anticipated, as discussed in the section entitled “Forward Looking Statements.”  The following discussion of our results of operations and financial condition should also be read in conjunction with our financial statements and notes to financial statements contained in this report.

 

Introduction

 

Blackhawk Biofuels, LLC (referred to herein as “we,” “us,” the “company,” “Blackhawk” or “Blackhawk Biofuels, LLC”) is a limited liability company organized under the laws of the State of Delaware on April 28, 2005.  We own and operate a biodiesel production plant in Danville, Illinois.  Until the end of 2008, we were a development stage company with no revenues from operations.  Our plant commenced operations in December 2008 and we received our first revenues from operations in January 2009.

 

Our plant has a design capacity to produce 45 million gallons of biodiesel per year (“mmgy”).  In addition, at full capacity the plant will produce approximately 16,800 tons of glycerin each year.  The plant consists principally of a materials handling and storage area, a transesterification reactor in which the biodiesel is produced, a storage and loading area for biodiesel and glycerin, truck scales and an administrative office.

 

With the completion of our animal fat pretreatment facilities in March 2009, our plant has the ability to utilize multiple feedstocks, including soybean oil, other vegetable oils, animal fats and used cooking oil.  The primary product of our plant is fuel grade biodiesel meeting ASTM D6751 standards.

 

Our plant is presently processing feedstocks, principally animal fats and used cooking oil, into biodiesel under month-to-month toll processing agreements.  These agreements have allowed us to operate our plant, generate some cash flow and meet most of our current obligations other than principal payments on debt and expenses incurred in connection with our proposed combination transaction with REG and two other biodiesel producers.

 

Merger Agreement to Combine Operations with Renewable Energy Group, Inc. and other Biodiesel Producers

 

On May 11, 2009 we executed an Agreement and Plan of Merger (the “Merger Agreement”) with Renewable Energy Group, Inc., a Delaware corporation (“REG”), a new Delaware holding company incorporated by REG (“Newco”) and a new Delaware limited liability company wholly owned by Newco.  Newco was created by REG for the purpose of acquiring REG, Blackhawk and two other biodiesel production companies in related transactions through four wholly-owned subsidiaries of Newco.  REG provides biodiesel management, feedstock procurement and product marketing services to the biodiesel market.  The two other companies are Central Iowa Energy, LLC, which owns a 30 mmgy biodiesel production plant in Newton, Iowa, and Western Iowa Energy, LLC, which owns a 30 mmgy biodiesel plant in Wall Lake, Iowa.  On August 7, 2009 we executed an Amended and Restated Agreement and Plan of Merger (the “Amended Merger Agreement”) that amended the terms of the Merger Agreement and was entered into in conjunction with amendments to merger or asset purchase agreements with the other companies.

 

Ownership of the operations of all four companies will be consolidated in the new holding company, which will be renamed Renewable Energy Group, Inc. following completion of the transaction.  The consolidated company will be owned by current REG stockholders and the current members of the three biodiesel production companies, including Blackhawk.  Under the terms of the Merger Agreement, Unitholders of Blackhawk, other than REG and its affililates, will receive 0.4479 of a share of Newco common stock and 0.0088 of a share of Newco preferred stock for each Class A Unit of Blackhawk held by them.  On that basis, Unitholders of Blackhawk will receive an aggregate of 6,753,100 shares of common stock and 132,679 shares of preferred stock of Newco, subject to

 

25



Table of Contents

 

rounding up for fractional shares.  Assuming that all of the related transactions are approved and close concurrently, Blackhawk unitholders will receive approximately 18.2% of the common stock and approximately 1.0% of the preferred stock of Newco to be issued and outstanding upon closing. These percentages are subject to increase if the transaction is not completed with either or both of the Iowa production companies but is completed with Blackhawk and REG.  Restrictions on the transfer of the Newco stock will be in effect until December 31, 2010 or until 180 days after the effective date of a registration statement for a qualifying initial public offering by Newco.  The Amended Merger Agreement provides that upon the closing of the transaction Ronald L. Mapes, the Chair of Blackhawk, will be appointed to serve as a director of Newco until the transfer restrictions on the Newco stock lapse.

 

The transaction is subject to approval by the stockholders or members of each of the four companies involved, satisfactory arrangements with lenders and other conditions, including customary regulatory approvals and closing conditions.  However, closing of the transaction among REG, Newco and Blackhawk is not conditioned on approval and closing with the other parties to the transaction.  The parties have agreed to cooperate in preparing a registration statement on Form S-4 to register with the Securities and Exchange Commission the Newco common stock and preferred stock to be issued in the transaction. A registration statement on Form S-4 was initially filed with the Securities and Exchange Commission on August 10, 2009 and the document is currently in review.  The registration statement contains a joint proxy statement/prospectus which will be provided to the members and stockholders of each of the parties for consideration in connection with meetings to be held to consider approval of the transaction.   It is presently anticipated that a meeting of the members of Blackhawk and closing of the transaction will occur in December 2009.  Meanwhile, Blackhawk is required to operate its business in the ordinary course and has agreed not to seek an alternative business combination transaction.  The Amended Merger Agreement may be terminated by Blackhawk, REG or Newco if the Closing does not occur by December 31, 2009, subject to limitations or extensions provided in the agreement or by mutual agreement of the parties.

 

A copy of the Amended Merger Agreement was filed as an exhibit to our Current Report on Form 8-K dated August 7, 2009 and is incorporated herein by reference.  The foregoing description of the Amended Merger Agreement is qualified in its entirety by reference to the full text of the Amended Merger Agreement.

 

We have several pre-existing relationships with REG.  REG purchased 1,000,000 of our Series A Units in our public offering which closed in March 2008.  In May 2008, REG supplied $21,700,000 in financing to us under a Subordinated Loan Agreement dated May 9, 2008 and a Convertible Subordinated Note.  We have issued 985,069 additional Class A Units to REG in lieu of cash interest otherwise due under the Convertible Subordinated Note.  The Convertible Subordinated Note is convertible into our Class A Units upon maturity of the note, prepayment of the note, the closing of an initial public offering by REG, a change of control of REG or three years after the date of the note at a conversion price of $2.00 per Unit.  REG also holds a warrant for the purchase of 51,563 Class A Units of the Company at an exercise price of $.01 per Unit.  We have a Management and Operational Services Agreement (“MOSA”) dated May 9, 2008 under which two REG affiliates, REG Services Group, LLC (“REG Services”) and REG Marketing & Logistics Group, LLC (“REG Marketing”) have responsibility for the overall management of our plant, procurement of feedstocks, marketing of our production, and performance of administrative, sales and marketing functions for us.  The MOSA also provides for the extension of trade credit by REG Services and REG Marketing to the Company in connection with the purchase of raw materials and sale of biodiesel by the Company and provides that REG Services is entitled to appoint one member to our board of managers.  We have also entered into toll processing agreements with REG Marketing which provide for us to process feedstock into biodiesel for the account of REG Marketing during each of the monthly periods from May 2009 through November 2009.  The foregoing agreements have previously been filed as exhibits to reports filed by us with the Securities and Exchange Commission.  The foregoing description of those agreements is qualified in its entirety by reference to the full text of those agreements.  For purposes of this report, references hereafter to REG shall be deemed to include REG Services and REG Marketing.

 

26



Table of Contents

 

Fiscal Three Months Results of Operations

 

During the three months ended September 30, 2009, we have been processing feedstocks, principally animal fats and used cooking oil, into biodiesel under month-to-month toll processing agreements.  These operations have allowed us to generate revenues sufficient to meet current cash operating expenses excluding principal payments on debt and expenses incurred in connection with our proposed combination transaction with REG and two other biodiesel producers.  Because we were in the development stage through December 31, 2008, we had no revenues from operations during the three months ended September 30, 2008.  The following table summarizes information from our financial statements and you should read these tables in conjunction with our financial statements and the notes thereto contained in this report.

 

 

 

Three Months Ended
September 30, 2009
(Unaudited)

 

Three Months Ended
September 30, 2008
(Unaudited)

 

 

 

Amount

 

Percent

 

Amount

 

Percent

 

Statement of Operations Data:

 

 

 

 

 

 

 

 

 

Revenues

 

$

2,638,575

 

100.00

%

$

 

 

Cost of Goods Sold

 

2,604,363

 

98.70

%

 

 

Gross Profit

 

34,212

 

1.30

%

 

 

Operating Expenses

 

(960,459

)

(36.40

)%

(378,635

)

 

Operating Loss

 

(926,247

)

(35.10

)%

(378,635

)

 

Other Income (Expense)

 

(746,669

)

(28.30

)%

(192,417

)

 

Net Loss

 

$

(1,672,916

)

(63.40

)%

$

(571,052

)

 

 

Revenues

 

Our revenues for the three months ended September 30, 2009 consisted of $2,638,575 in sales to REG and we had no sales of biodiesel to parties other than REG during the period.  The sales to REG consisted entirely of payments received under monthly toll processing agreements for the production of biodiesel.  Revenues from our toll processing agreements with REG are based on a per gallon production fee which varies based on the quantity produced.  Because we were in the development stage through December 31, 2008, we had no revenues from operations during the three months ended September 30, 2008.  Consequently, there is no comparison in revenues that can be made between the 2009 and 2008 periods.

 

The major challenge that we and others in the biodiesel industry face is the low price for biodiesel in the market.  Biodiesel prices generally correlate with the price of diesel fuel.  With energy prices generally, the price of diesel fuel has declined in the past year and has remained lower than the price of biodiesel.  This factor, combined with the cost of biodiesel production, has resulted in an adverse biodiesel market, excess capacity in the industry relative to demand, curtailment of production and decreased biodiesel revenues for us and others in the industry.

 

Cost of Goods Sold

 

Our cost of goods sold in the three month period ended September 30, 2009 was $2,604,363.  Normally, the principal component of the cost of goods sold in the production of biodiesel is the soybean oil and animal fats feedstock that may account for approximately 80% of the cost of operations of a biodiesel plant.  Other cost components normally include methanol and other chemicals used in the production process, natural gas and electricity to power the plant, labor and depreciation on plant and equipment.  Cost of goods sold would also reflect gain or loss in the fair value of commodities derivative instruments utilized to protect against variations in the feedstock and biodiesel markets.  We are currently operating pursuant to toll processing agreements under which we produce biodiesel for REG and other third parties using feedstock supplied by REG and the third parties.  Under the toll processing agreements, because we do not purchase feedstocks and sell biodiesel for our own account, the current principal components of our cost of goods sold are processing chemicals, utilities and depreciation.

 

27



Table of Contents

 

Cost of goods sold was approximately 99% of our revenues during the period ended September 30, 2009.  This is principally a result of our less than optimal plant utilization during the period and high depreciation relative to our level of operations.  Our plant utilization during the three month period was approximately 58% of our plant capacity.

 

The market price for soybean oil relative to the market price for biodiesel has made it difficult for our plant and others in the industry to operate profitably.  Our pretreatment facility for animal fats was completed in March 2009.  Our ability to utilize animal fats and used cooking oil, which have historically been less costly than soybean oil, has improved our ability to operate on a cash breakeven basis.  However, this development has not improved our financial position sufficiently to allow us to operate successfully as an independent producer and we have found it necessary to enter into toll processing agreements with REG in order to operate at a level that is marginally sustainable from a current operating standpoint.  We have been operating under toll processing agreements using animal fat and used cooking oil feedstocks.  Greater demand for animal fats and used cooking oil in the biodiesel industry could increase the price of those feedstocks and reduce the favorable impact that animal fats and used cooking oil have on our results even in a toll processing mode of operation.

 

Operating Expenses

 

For the three months ended September 30, 2009, our operating expenses increased $581,824 or 154% from $378,635 to $960,459 as compared to the three months ended September 30, 2008.  The increase was due to a $291,913 increase in general and administrative expense and a $289,911 increase in professional fees.  The increase in general and administrative expense is principally due to the payment of monthly fees to REG under the MOSA and rail load out fees paid to Bunge North America, Inc. at our Danville plant site.  A significant portion of the professional fees during the three months ended September 30, 2009 were incurred in connection with our proposed combination transaction with REG and two other biodiesel producers.

 

Other Income (Expense)

 

Other income (expense) for the three months ended September 30, 2009 was ($746,669) compared to other income (expense) of ($192,417) in the three months ended September 30, 2008, an increase of $554,252 or 288%.  The result in the September 30, 2009 period was principally attributable to interest expense on financing for our plant and operations, which totaled $731,598.  By contrast, during the three months ended September 30, 2008, other income (expense) principally reflected a $264,598 loss on commodity derivative instruments, which was partially offset by interest income of $51,165 and a change in the fair value of an interest rate swap agreement of $21,016.  The interest income during the three months ended September 30, 2008 was the result of the investment of the proceeds of our public offering of Units during that period.  The interest expense in the three months ended September 30, 2009 is a direct consequence of the investment of the proceeds of our offering and debt financing proceeds in the construction and commencement of operations of our plant.  The $781,133 difference between interest income in the prior period and interest expense in the three months ended September 30, 2008 is the principal factor impacting the change in other income (expense) between the periods.

 

Net Loss

 

Our net loss for the three months ended September 30, 2009 was $1,672,916 which was principally a consequence of our loss from operations and interest expense.  In the three months ended September 30, 2008, we had a net loss of $571,052, which was primarily the result of operating expenses and the loss on commodity derivative instruments during that period.  The increase in net loss between the periods was $1,101,864 or 193%.

 

28



Table of Contents

 

Fiscal Nine Months Results of Operations

 

Following the completion of our plant and commencement of plant operations to process biodiesel from soybean oil feedstock, we received our first revenues from operations and transitioned from the development stage to the operations stage at the beginning of 2009.  Construction of a preliminary treatment facility to process animal fats at our plant was substantially completed on March 23, 2009. Beginning in March 2009, we have been processing feedstocks, principally animal fats and used cooking oil, into biodiesel under month-to-month toll processing agreements, which has allowed us to generate revenues sufficient to meet current cash operating expenses excluding principal payments on debt and expenses incurred in connection with our proposed combination transaction with REG and two other biodiesel producers.   Because we were in the development stage through December 31, 2008, we had no revenues from operations during the nine months ended September 30, 2008.  The following table summarizes information from our financial statements and you should read these tables in conjunction with our financial statements and the notes thereto contained in this report.

 

 

 

Nine Months Ended
September 30, 2009
(Unaudited)

 

Nine Months Ended
September 30, 2008
(Unaudited)

 

 

 

Amount

 

Percent

 

Amount

 

Percent

 

Statement of Operations Data:

 

 

 

 

 

 

 

 

 

Revenues

 

$

6,168,850

 

100.00

%

$

 

 

Cost of Goods Sold

 

8,403,297

 

136.22

%

 

 

Gross Loss

 

(2,234,447

)

(36.22

)%

 

 

Operating Expenses

 

(2,956,639

)

(47.93

)%

(1,299,682

)

 

Operating Loss

 

(5,191,086

)

(84.15

)%

(1,299,682

)

 

Other Income (Expense)

 

(1,933,622

)

(31.34

)%

600,091

 

 

Net Loss

 

$

(7,124,708

)

(115.49

)%

$

(699,591

)

 

 

Revenues

 

We received our first revenues from operations at the beginning of 2009.  Because we were in the development stage through December 31, 2008, we had no revenues from operations during the nine months ended September 30, 2008.  Consequently, there is no comparison in revenues that can be made between the 2009 and 2008 periods.  Our revenues from operations are derived principally from sales of biodiesel and tolling arrangements for the production of biodiesel.

 

Our revenues for the nine months ended September 30, 2009 consisted of $6,119,117 in sales to REG through its wholly-owned subsidiary, REG Marketing, and $49,733 from government biodiesel incentive programs.  The sales to REG consisted of $1,850,709 in direct sales and $4,268,408 in payments received under toll processing agreements with REG.  Because our revenues were generated principally from the production of biodiesel under toll processing agreements with REG following completion of our animal fat pretreatment facility in March 2009, most of our revenues in the nine month period were received in the final six months of the period.

 

We had direct sales of approximately 670,000 gallons of biodiesel during the nine month period ended September 30, 2009, all of which occurred in the first three months of the period.  Revenues from our toll processing agreements are based on a per gallon production fee which varies based on the quantity produced.

 

The major challenge that we and others in the biodiesel industry face is the low price for biodiesel in the market.  Biodiesel prices generally correlate with the price of diesel fuel.  With energy prices generally, the price of diesel fuel has declined in the past year and has remained lower than the price of biodiesel.  This factor, combined with the cost of biodiesel production, has resulted in an adverse biodiesel market, excess capacity in the industry relative to demand, curtailment of production and decreased biodiesel revenues for us and others in the industry.

 

29



Table of Contents

 

Cost of Goods Sold

 

Our cost of goods sold in the nine month period ended September 30, 2009 was $8,403,297.  Normally, the principal component of the cost of goods sold in the production of biodiesel is the soybean oil and animal fats feedstock that accounts for approximately 80% of the cost of operations of a biodiesel plant.  Other cost components normally include methanol and other chemicals used in the production process, natural gas and electricity to power the plant, labor and depreciation on plant and equipment.  Cost of goods sold would also reflect gain or loss in the fair value of commodities derivative instruments utilized to protect against variations in the feedstock and biodiesel markets.  Beginning in March 2009, we have been operating pursuant to toll processing agreements under which we produce biodiesel for the account of REG and other third parties using feedstock supplied by REG and the third parties.  Under the toll processing agreements, because we do not purchase feedstocks and sell biodiesel for our own account, the current principal components of our cost of goods sold are payments to REG under our MOSA, utilities and depreciation.

 

Cost of goods sold was approximately 136% of our revenues during the nine month period ended September 30, 2009.  This is principally a result of our low plant utilization during the period, high cost of feedstocks relative to biodiesel prices during our start-up operations at the beginning of 2009 and high depreciation relative to our level of operations.   Our plant utilization during the nine months period was approximately 34% of our plant capacity.

 

The market price for soybean oil relative to the market price for biodiesel has made it difficult for our plant and others in the industry to operate profitably.  Our pretreatment facility for animal fats was completed in March 2009.  Beginning in March 2009, our ability to utilize animal fats and used cooking oil, which have historically been less costly than soybean oil, has improved our ability to operate on a cash breakeven basis.  However, this development has not improved our financial position sufficiently to allow us to operate successfully as an independent producer and we have found it necessary to enter into toll processing agreements with REG in order to operate at a level that is marginally sustainable from a current operating standpoint.  Since March 2009, we have been operating under toll processing agreements using animal fat feedstocks and used cooking oil.  Greater demand for animal fats and used cooking oil in the biodiesel industry could increase the price of those feedstocks and reduce the favorable impact that animal fats and used cooking oil have on our results even in a toll processing mode of operation.

 

Operating Expenses

 

For the nine months ended September 30, 2009, operating expenses increased $1,656,957 or 127% from $1,299,682 to $2,956,639 as compared to the nine months ended September 30, 2008.  The increase was due to an $856,588 increase in general and administrative expense and an $800,399 increase in professional fees expense. The increase in general and administrative expense is principally due to staffing and general costs incurred to administer our operations, the payment of monthly fees to REG under the MOSA, rail load out fees paid to Bunge and annual debt financing renewal and administrative fees.  A significant portion of the professional fees were incurred in connection with our proposed combination transaction with REG and two other biodiesel producers.

 

Other Income (Expense)

 

Other income (expense) for the nine months ended September 30, 2009 was ($1,933,622) compared to other income of $600,091 in the nine months ended September 30, 2008.  The result in the September 30, 2009 period was attributable to interest expense on financing for our plant and operations, totaling $2,197,807, which offset a $253,957 change in the fair value of an interest rate swap agreement and a small amount of other income and interest income.  By contrast, during the nine months ended September 30, 2008, we earned $891,625 in interest income, which was the result of the investment of the proceeds of our public offering of Units during that period.  This income was offset to some extent by a $264,598 loss on commodities derivative instruments.  The $2,533,713 difference in the other income (expense) results for the periods is a direct consequence of the investment of the proceeds of our offering and financing proceeds in the construction and commencement of operations of our plant.

 

Net Loss

 

Our net loss for the nine months ended September 30, 2009 was $7,124,708 which was principally a consequence of our loss from operations and interest expense.  In the nine months ended September 30, 2008, we had a net loss of $699,591, which was primarily the result of an excess of operating expenses over interest income during that period.   The increase in net loss between the periods was $6,425,117 or 918%.

 

30



Table of Contents

 

Financial Position

 

 

 

September 30, 2009

 

December 31, 2008

 

 

 

(unaudited)

 

 

 

Balance Sheet Data:

 

 

 

 

 

Assets:

 

 

 

 

 

Current Assets

 

$

2,878,872

 

$

9,266,530

 

Property, Plant and Equipment, net

 

63,474,156

 

63,896,817

 

Other Assets

 

276,322

 

368,431

 

Total Assets

 

$

66,629,350

 

$

73,531,778

 

 

 

 

 

 

 

Liabilities and Members’ Equity:

 

 

 

 

 

Current Liabilities

 

$

28,357,096

 

$

6,371,911

 

Long-Term Debt

 

21,625,585

 

44,411,476

 

Members’ Equity

 

16,646,669

 

22,748,391

 

Total Liabilities and Members’ Equity

 

$

66,629,350

 

$

73,531,778

 

 

Funding for our project planning and development activities was originally provided by a $3,500,000 seed capital financing and grants from the United States Department of Agriculture (“USDA”) and the Illinois Soybean Board in the aggregate amount of $102,500.  The completion of our public offering of units, which provided $25,102,000 in equity financing, our $24,650,000 construction/term debt financing with Fifth Third Bank (“Fifth Third”), our $5,000,000 revolving line of credit from Fifth Third and our $21,700,000 subordinated debt financing with REG Ventures provided us with the capital necessary to acquire the under-construction assets of our plant, complete construction of our plant and commence operations.

 

At September 30, 2009, we had cash and restricted cash totaling $2,122,693, a decrease of $5,452,345 or 72% from $7,575,038 at December 31, 2008.  The decrease was a consequence of the use of cash in operations.  Accounts receivable at September 30, 2009 amounted to $332,921 against no accounts receivable at December 31, 2008.  Inventories of $94,223 at September 30, 2009 reflected a decrease of $1,228,633 or 93% from $1,322,856 in inventories at December 31, 2008.  The reduced inventories and increased accounts receivable was a consequence of the conversion of inventories to receivables during a period of reduced plant operations and the generation of receivables from toll processing operations which did not involve ownership of significant feedstocks or product by us.  Total current assets at September 30, 2009 were $2,878,872, a reduction of $6,387,658 or 69% from $9,266,530 at December 31, 2008.

 

Net property, plant and equipment of $63,474,156 at September 30, 2009 was essentially unchanged from $63,896,817 at December 31, 2008.  The principal shift within the category was the move of construction in process assets to completed buildings and plant and process equipment.  Depreciation increased from $204,920 to $2,874,044 which reflected depreciation on most of our plant and equipment since placement in service.

 

Total assets of $66,629,350 at September 30, 2009 declined from $73,531,778 at December 31, 2008, a decline of $6,902,428 or 9%, principally as a result of decreased current assets and an increase in accumulated depreciation.

 

As of September 30, 2009, we had current liabilities of $28,357,096 compared to $6,371,911 at December 31, 2008, an increase of $21,985,185 or 345%.  The increase was attributable principally to the reclassification of our term loan with Fifth Third Bank from long-term debt to current maturities of long-term debt as a consequence of our failure to be in compliance with certain covenants in our term loan agreement which would permit Fifth Third Bank to declare our term loan in default if it chose to do so.  The reclassification resulted in an increase in current maturities of long-term debt from $1,848,753 at December 31, 2008 to $24,444,583 at September 30, 2009, an increase of $22,595,830 or 1,222%.  Current liabilities accounts related to operations, including line of credit, accounts payable, accounts payable — related party, accrued expenses and accrued interest as an aggregate increased from $904,424 to $2,553,468, a difference of $1,649,044, or 182%, which is a consequence of our lack of cash resources available to fund our operations.  Also included in current liabilities was an interest rate swap liability at

 

31



Table of Contents

 

fair value of $1,159,080. The interest rate swap liability declined $253,957 or 18% from $1,413,037 at December 31, 2008 principally due to the decrease in interest rates during the period.  Construction payable — related party decreased from $2,109,985 at December 31, 2008 to $199,965 at September 30, 2009, a decrease of $1,910,020 or 91%, as payments were made from restricted cash to fund plant upgrades.

 

Long-term debt at September 30, 2009 was $21,625,585 compared to $44,411,476 at December 31, 2008, a difference of $22,785,891 or 51%.  This reflected the reclassification of our term debt with Fifth Third Bank from long-term debt to current maturities on long-term debt.

 

Our accumulated deficit of $14,000,998 at September 30, 2009 increased $7,124,708 or 104% from $6,876,290 at December 31, 2008.  Total members’ equity at September 30, 2009 was $16,646,669 compared to $22,748,391 at December 31, 2008, a decline of $6,101,722 or 27%.

 

Liquidity and Capital Resources

 

Construction of the animal fat pre-treatment facility for our plant was completed and operation of that facility commenced in late March 2009.  Due to market conditions, particularly with respect to soybean oil feedstock, our plant as a whole operated only sporadically between January 1, 2009 and March 31, 2009.  As a consequence, we generated only $1,914,354 in revenues in the first quarter of 2009 and did not replenish working capital used to fund fixed and variable costs incurred during the first quarter of 2009.  In the second and third quarters of 2009, the availability of our animal fat pretreatment facility allowed us to operate our plant using animal fat and used cooking oil feedstocks and we entered into monthly toll processing agreements with REG beginning in May 2009 to process animal fat and used cooking oil feedstock into biodiesel.  This resulted in revenues of $1,615,925 in the second quarter and $2,638,575 in the third quarter.  The second and third quarter revenues were predominantly derived from toll processing which requires less related expense and results in better cash flow and liquidity consequences than was the case with revenues in the first quarter.  Principal payments on our outstanding term loan agreement with Fifth Third, which commenced in April, were deferred pursuant to a verbal understanding with the bank following our principal payment in April, which reduced demands on our cash position during the balance of the second quarter and during the third quarter.  Consequently, we have been able to meet most of our current cash obligations directly related to our production operations during the second and third quarters of 2009 and reduce the rate of deterioration of our working capital.  However, we have not had cash resources available that would be sufficient to allow us to make principal payments on our debt or to pay expenses incurred in connection with our proposed combination transaction with REG and two other biodiesel producers.

 

Consequently, our working capital position remains inadequate.  Our first principal payment on our term loan from Fifth Third, in the amount of $205,417, was made on April 1, 2009.  Monthly principal payments have been deferred since that date and we are presently in negotiations with Fifth Third to amend the terms of our loan and reschedule payments.  Subject to the outcome of those negotiations, at some point in the future we will find it necessary to use any available cash resources to make our principal payments, together with accrued interest, on our term loan from Fifth Third.  Our current failure to be in compliance with certain covenants in our term loan agreement would permit Fifth Third Bank to declare our term loan in default and require payment of the entire balance of our term loan if it chose to do so.

 

Our ability to manage a very restricted working capital scenario depends on a number of factors.

 

First, our ability to continue to produce biodiesel under toll processing agreements with REG on a month-to-month or longer term basis will be essential to our ability to operate and generate cash to meet current obligations. We do not have adequate cash resources to finance normal operations that would include the necessity to pay for feedstocks, hedging and other operating expenses on a current basis while providing normal credit terms in the biodiesel market.  Assuming toll processing agreements are available to us, the volumes of production under the agreements will need to be adequate to generate the cash required to operate.

 

Second, our commitment from Fifth Third to provide $5,000,000 in revolving credit expired on May 8, 2009 and the availability of current credit from Fifth Third remains subject to our negotiations with Fifth Third regarding our term loan and general credit availability.  There is no assurance that our negotiations with Fifth Third will be successful or that we will obtain revolving credit from Fifth Third in the amount of $5,000,000 or any other amount.

 

32



Table of Contents

 

Even if Fifth Third extends revolving credit to us on the same or similar terms as the prior credit, the amount available to us will depend on our ability to generate inventories and receivables that qualify for drawings by us.  Under the original terms of the revolving credit, the credit was available only to the extent of 50% of qualifying inventories and 75% of qualifying receivables.  Thus, our ability to qualify for drawings will very likely depend on our ability to acquire inventories and generate receivables, which itself depends on the availability of working capital.  Consequently, revolving credit is not an immediate solution to our working capital needs.

 

Third, the extension of credit by REG Marketing under the REG Services Agreement, which provides for the extension of trade credit upon the sale of biodiesel production by us unrelated to our toll processing agreements, is also limited and does not respond adequately to our current working capital needs.

 

Fourth, in current market conditions, it is difficult to obtain any financing for feedstock and other production inputs from vendors or other sources of feedstock and inputs.  Most importantly, our Oil Feedstock Supply Agreement with Bunge does not provide for any deferred payment of financing that would, in effect, reduce or defer working capital needs.

 

Fifth, it is also very difficult to obtain advance or immediate payment from biodiesel customers for product ordered and delivered.  Again, this is a characteristic of the condition of the biodiesel industry today.  This has made it necessary for us to rely on toll processing agreements with REG which result in lower accounts receivable and earlier payment terms.  While tolling arrangements reduce our working capital requirements, they do not provide sufficient working capital for normal operations.

 

Finally, the relationship of feedstock prices, principally the price of soybean oil, and the price of biodiesel in the market typically results in a very small margin of profit on biodiesel production and sales, and frequently results in operating losses when prices are matched for any given day or period.  Tolling agreements alleviate this risk but do not build adequate working capital to assume or manage the risk encountered normal operations.

 

We have attempted to address both our working capital and profit and loss issues by selectively entering into purchase orders with customers in circumstances where the price of inputs and product yield an operating profit and positive cash flow.  We have had limited success with this approach to reducing our decline in working capital and have had no direct purchase orders from customers unrelated to REG since March 2009.

 

The toll processing agreements that we have entered into with REG have provided a margin to us for processing feedstock owned and provided to us by REG into biodiesel to be sold by REG.  Because we do not take title to either the feedstock or product, our working capital requirements are substantially reduced in tolling arrangements.  Generally, such tolling agreements may be quite short term, amounting to little more than a limited quantity purchase order, or could be of a longer duration, such as several months or even one or two years.  Our agreements with REG have been entered into on a monthly basis. Unless a tolling agreement relates to substantially our entire capacity, we could combine tolling with the processing of biodiesel under purchase orders to maximize utilization of our plant.  However, limitations on commingling of feedstock and product limit our ability to process biodiesel outside the tolling arrangement for ourselves or other parties.  If the tolling arrangement requires only a small portion of our capacity, we could find ourselves in a position of incurring more in fixed and variable costs than the tolling arrangement would cover, which could result in a drain on working capital rather than a benefit to us.

 

Because we are attempting to address our working capital needs in a market where it is very difficult to predict the feedstock and biodiesel prices or the success of any operating strategy, we cannot predict whether our strategies will be successful in the short or long term.  If we find that we are not able to operate profitably and either reduce the working capital that we require, generate enough working capital to continue to operate, renegotiate the terms of our long-term debt or locate additional debt or equity financing to fulfill our needs, we may find it necessary to curtail operations of our plant.  If that occurs, the time and expense required to recommence operations may be significant and may itself be a significant barrier to continued operations.

 

A significant challenge to us will be our ability to make timely payments on our term loan from Fifth Third.  Our first principal payment on the loan, in the amount of $205,417, was made on April 1, 2009.  Subsequent principal payments due on the first of each month in the amount of $205,417 have been deferred based on a verbal understanding with Fifth Third pending completion of negotiations with Fifth Third to modify and extend the

 

33



Table of Contents

 

schedule of principal payments on the loan and make other modifications in the terms of the agreement.  Under our term loan agreement, we have deposited $2,000,000 in a debt service account with Fifth Third which can be drawn on by the bank in the event of any failure on our part to make a payment when due, but that does not replace any obligation to pay by us.  Any failure on our part to make a payment to Fifth Third, without the consent of or waiver by Fifth Third, would constitute a default under the term loan agreement and could lead to action on the part of Fifth Third to collect payment, accelerate the maturity of the loan, foreclose on our plant as collateral for its loan and place us into bankruptcy.  Although we will take any action possible to forestall these eventualities, our inability to operate successfully could lead to one or more of these consequences.  In addition, our term loan agreement contains a number of covenants that we currently fail to meet which, if not modified, could also lead to the same consequences.  Although we would seek deferrals, waivers or amendments of any covenant that we breach or threaten to breach, there is no assurance that Fifth Third would agree to any action that would reduce the effectiveness of any covenant.

 

Our subordinated debt financing with REG Ventures does not provide for immediate principal payments and allows interest payments to be made in the form of our Class A Units instead of cash, at our election.  Through the year ended December 31, 2008 and the first nine months of fiscal year 2009, we have made all interest payments to REG Ventures in the form of units, amounting to 542,224 units for interest due in the year ended December 31, 2008 and 442,845 units for interest due in the first nine months of 2009.  However, the agreement with REG Ventures also contains provisions similar to those contained in the term loan agreement with Fifth Third and a cross-default provision that treats a default on the Fifth Third agreement as a default on the REG Ventures Agreement.

 

The foregoing circumstances and uncertainties raise substantial doubt about our ability to continue as a going concern, as discussed in Note 9 to our financial statements for the nine months ended September 30, 2009.  If we find that it is impossible to operate profitably, reduce the working capital that we require, generate enough working capital to continue to operate, comply with covenants on our loans or make debt payments when due, amend our term debt agreement with Fifth Third Bank, or locate additional debt or equity financing to fulfill our needs, we may find it necessary to curtail operations of our plant, attempt to enter into a merger, acquisition or roll-up transaction with a stronger partner, consider reorganization in bankruptcy or liquidate our company.  Our proposed combination with REG and other parties as provided in the Amended Merger Agreement is intended to address these issues.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements.

 

Critical Accounting Estimates

 

In accordance with United States generally accepted accounting principles, we use estimates and assumptions in preparing our financial statements.  These estimates and assumptions may have an impact on the amounts of revenues, expenses, assets and liabilities reported in our financial statements, particularly with reference to the valuation of derivatives, inventory and unit-based compensation.  We believe that the estimates and assumptions we have used with respect to the financial statements included in this report are reasonable.

 

Our financial statements have been prepared assuming that we will continue as a going concern.  As discussed in Note 9 to our financial statements for the nine months ended September 30, 2009, our significant operating losses, economic state of the biodiesel industry and volatile commodities prices raise substantial doubt about our ability to continue as a going concern.  The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

We account for equity-based compensation in accordance with ASC 718. Under the provisions of ASC 718, equity-based compensation cost is estimated at the grant date based on the award’s fair value as calculated by the Black-Scholes-Merton (“BSM”) option-pricing model and is recognized as expense ratably over the requisite service period. The BSM model requires various highly judgmental assumptions including volatility, forfeiture rates, and expected option life. If any of the assumptions used in the BSM model change significantly, equity-based compensation expense may differ materially in the future from that recorded in the current period.

 

34



Table of Contents

 

Significant estimates also include the fair value of warrants issued to members of our Board of Managers and to a consultant to our company.  It is at least reasonably possible that these estimates may change in the near term.

 

Item 3.  Quantitative and Qualitative Disclosures About Market Risk.

 

Not applicable.

 

Item 4.  Controls and Procedures.

 

Our management, including Ronald L. Mapes, our Chair (principal executive officer) and Ronald Fluegel, our Treasurer (principal financial officer), have reviewed and evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) as of September 30, 2009.  Our management, including our Chair, Ron Mapes, (the principal executive officer), and Ronald Fleugel, our Treasurer, (principal financial officer), have reviewed and evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2009.  Based upon this review and evaluation, these officers have concluded that our disclosure controls and procedures were not effective based upon a material weakness relating to the lack of oversight in identifying and determining significant accounting transactions or situations that require adjustment or reclassification.  Our management will continue our efforts to remediate this material weakness through ongoing process improvements and the implementation of enhanced policies and improving standards.  We are in the process of strengthening internal controls including enhancing our internal control systems and procedures to assure that these weaknesses are corrected and remediated.  A material weakness will not be considered remediated until the remedial procedure has operated for an appropriate period, has been tested, and management has concluded that it is operating effectively.

 

Our management, including our principal executive officer and principal financial officer, have reviewed and evaluated any changes in our internal control over financial reporting that occurred as of September 30, 2009 and there has been no change that has materially affected or is reasonably likely to materially affect our internal control over financial reporting.

 

PART II — OTHER INFORMATION

 

Item 1.  Legal Proceedings.

 

None.

 

Item 1A.  Risk Factors.

 

Not applicable.

 

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.

 

On December 15, 2006, a registration statement (No. 333-136353) for an offering of a minimum of 10,000,000 and a maximum of 17,500,000 of our Class A Units was declared effective.  The offering price for the Units was $2.00 per Unit, for a minimum offering of $20,000,000 and a maximum of $35,000,000.  The offering commenced on December 22, 2006.  On December 15, 2007 we completed the offering having sold a total of 12,551,000 Units and raising a total of $25,102,000.  On March 14, 2008 we broke escrow on the offering.  We incurred $656,411 in total offering expenses, of which approximately $500,000 was paid from resources other than proceeds of the offering and approximately $150,000 was paid from the proceeds of the offering.  The total offering expenses have been charged against equity for accounting purposes.  No underwriting or finder fees or expenses were incurred in the offering.  Except for a small amount of out-of-pocket expenses reimbursed to our officers and managers, none of such payments were made to officers, managers, holders of more than 10% of our equity securities or our affiliates.  The following table sets forth a reasonable estimate of the use of our offering proceeds through September 30, 2009:

 

35



Table of Contents

 

 

 

From December 15, 2006
to September 30, 2009

 

Total Offering Proceeds

 

$

25,102,000

 

Offering Expenses Paid from Proceeds (1)

 

150,000

 

Offering Proceeds Net of Offering Expenses

 

$

24,952,000

 

Use of Proceeds:

 

 

 

Purchase of Assets under Construction

 

$

5,400,000

 

Site Development Expenses

 

150,000

 

Financing Fees and Expenses

 

750,000

 

Establishment of Debt Service Fund

 

2,000,000

 

Interest

 

680,000

 

Construction Costs

 

11,200,000

 

Equipment and Inventories

 

30,000

 

Preproduction Period and Operating Expenses

 

4,532,000

 

Insurance

 

150,000

 

Professional and Printing Fees

 

60,000

 

Total Offering Proceeds Used

 

$

24,952,000

 

Offering Proceeds Remaining Available for Use

 

$

0

 

 


(1)  Total Offering Expenses were $656,411.  Approximately $150,000 of such expenses was paid from the proceeds of the offering.  The balance of the offering expenses was paid from other resources prior to the availability of the offering proceeds.

 

The expenditures for construction costs, relating to the completion of our biodiesel facility, were paid to or through REG Construction & Technology Group, LLC, a subsidiary of REG, acting as general contractor under a Design-Build Agreement dated May 9, 2008.

 

The Company entered into a Subordinated Loan Agreement dated May 9, 2008 with REG Ventures, LLC, an affiliate of REG, and issued to REG Ventures a convertible promissory note in the amount of $21,700,000.  This note was principally in payment for 1,980,488 shares of common stock of REG delivered to BCA under the terms of our Purchase Agreement for the under-construction assets of the Danville facility.  It also reimbursed REG for 127,273 shares of preferred stock of REG issued to Bunge in connection with an oil feedstock supply agreement entered into between the Company and Bunge.  Interest is based on LIBOR plus 5% and the note is due May 9, 2013.  The Company may, if it wishes, pay interest due in Class A Units of the Company at a rate of $2.00 per Unit.  In accordance with this provision, the Company issued Class A Units to REG on in satisfaction of interest accrued through September 30, 2009 as follows:

 

Interest Payment 
Due Date

 

Interest Payment
Amount

 

Unit Issuance Date

 

Units Issued

 

June 30, 2008

 

$

239,875

 

August 13, 2008

 

119,937

 

September 31, 2008

 

414,162

 

October 8, 2008

 

207,080

 

December 31, 2008

 

430,414

 

January 14, 2009

 

215,207

 

March 31, 2009

 

295,965

 

May 8, 2009

 

147,982

 

June 30, 2009

 

296,607

 

July 16, 2009

 

148,303

 

September 30, 2009

 

293,121

 

October 13, 2009

 

146,560

 

 

 

$

1,970,144

 

 

 

985,069

 

 

36



Table of Contents

 

The obligations of the Company to REG are secured on a subordinated basis by substantially all of the assets of the Company.  The promissory note is convertible into Class A Units of the Company upon maturity, prepayment, the closing of an initial public offering by REG, a change of control of REG or three years after the date of the note.  Exemption for the issuance of the note, the underlying Class A Units issuable upon conversion of the note and the Class A Units issued in lieu of interest is claimed under Section 4(2) of the Securities Act of 1933 as transactions not involving a public offering.

 

The Company also issued a Unit Purchase Warrant dated May 9, 2008 to REG Ventures, LLC, for the purchase of 51,563 Class A Units of the Company at an exercise price of $.01 per Unit.  The warrant was issued in consideration of REG providing a guaranty for a portion of the Company’s obligations under its Loan Agreement with Fifth Third.  The warrant is exercisable for one year after issuance to the extent of 20% of the Units covered thereby and is exercisable for an additional 20% of the Units on the first four anniversaries of the date of issuance of the warrant.  Exemption for the issuance of the warrant and the underlying Class A Units is claimed under Section 4(2) of the Securities Act of 1933 as a transaction not involving a public offering.

 

Item 3.  Defaults upon Senior Securities.

 

None

 

Item 4.  Submission of Matters to a Vote of Security Holders.

 

None.

 

Item 5.  Other Information.

 

None.

 

Item 6.  Exhibits.

 

The following exhibits are filed as part of, or are incorporated by reference into, this report:

 

Exhibit No.

 

Description

*31.1

 

Certification pursuant to Rule 15d-14(a)

 

 

 

*31.2

 

Certification pursuant to Rule 15d-14(a)

 

 

 

*32.1

 

Certification pursuant to Rule 15d-14(b) and 18 U.S.C. Section 1350

 

 

 

*32.2

 

Certification pursuant to Rule 15d-14(b) and 18 U.S.C. Section 1350

 


*    Filed herewith.

 

37



Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

BLACKHAWK BIOFUELS, LLC

 

 

 

 

Date: November 13, 2009

/s/ RONALD L. MAPES

 

Ronald L. Mapes

 

Chair (Principal Executive Officer)

 

 

 

 

Date: November 13, 2009

/s/ RONALD FLUEGEL

 

Ronald Fluegel

 

Treasurer (Principal Financial and Accounting Officer)

 

38